Related Experiment Video
Updated: Mar 18, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
Donepezil for Korsakoff Syndrome
Marisa Fallone1, Mauran Sivananthan, Melvin Joseph
1Department of Behavioral Health, Henry Ford Health System, Detroit, MI.
Donepezil, an Alzheimer disease medication, may improve symptoms of Korsakoff syndrome, a memory disorder caused by thiamine deficiency. This case study suggests potential benefits for cognition and affect in patients with Korsakoff syndrome.
Area of Science:
- Neuroscience
- Neurology
Background:
- Korsakoff syndrome is a severe neurocognitive disorder resulting from thiamine deficiency.
- It is characterized by memory impairment and confabulation.
- Wernicke's encephalopathy precedes Korsakoff syndrome and is reversible, but Korsakoff syndrome has limited treatment options.
Purpose of the Study:
- To investigate the potential benefits of donepezil in a patient with Korsakoff syndrome.
- To explore off-label therapeutic options for Korsakoff syndrome.
Main Methods:
- Case study based on clinical records and direct patient observations.
- Retrospective analysis of patient's response to donepezil treatment.
Main Results:
- The patient with Korsakoff syndrome showed improvement in cognition, motivation, and affect after initiating donepezil.
- Donepezil was well-tolerated in this case.
Conclusions:
- Off-label use of donepezil may be beneficial for managing symptoms of Korsakoff syndrome.
- Larger studies are required to confirm the safety and efficacy of donepezil for Korsakoff syndrome.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:46Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Related Concept Videos
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Drug Dosing: Geriatric Patients